Form D · Other
EFX Laboratories Inc.
Calgary, A0 · CIK 0001722789
Offering snapshot reported Nov 15, 2017 · SEC filing
- Reported sold
- $370K Offering amount: $370K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 31, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 15, 2017 | Initial | $369,607 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-298870
offering of common shares at $0.15 cdn.
offering of common shares at $0.15 cdn.
Source: Form D, filed Nov 15, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Black | Director |
| Chris Burchell | Executive |
| Jeff Galatiuk | Director |
| Suzanne Jones | Director |
| Gabriel Ollivier | Director |
| Shawn Ripley | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
203, 535 10 Th Avenue Sw
Calgary, A0, T2R0A8
Calgary, A0, T2R0A8